News Announcement

Aurobindo Pharma: Announcement under Regulation 30 (LODR)-Change in Directorate

The Board of Directors of the Company on March 29 2019 has approved the reappointment of Mr. K. Ragunathan (DIN: 00523576) as an Independent Director of the Company for the second term for a period of 5 years from April 1 2019 to March 31 2024 subject to the approval of the shareholders at the ensuing Annual General Meeting of the Company. The Profile of Mr. K. Ragunathan is enclosed as Annexure.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.